The Ameliorating Effect of Adipose Tissue Stem Cells on Liver Function in Experimental Rats with Liver Fibrosis
محل انتشار: نشریه بین المللی علوم تغذیه، دوره: 7، شماره: 4
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 219
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJNS-7-4_006
تاریخ نمایه سازی: 19 دی 1401
چکیده مقاله:
Background: As mesenchymal stem cells have anti-inflammatory and immunomodulating properties and can be a therapeutic option in regenerative medicine, this study was undertaken to determine ameliorating effect of adipose tissue stem cells (AdSCs) on liver function in experimental rats with liver fibrosis.Methods: Thirty-two rats were randomly divided into four equal groups including control group ۱ receiving just ۱ mL/kg of distilled water, twicea week for ۸ weeks (intraperitoneally: IP). Control group ۲ received ۱mL/kg of olive oil, similarly. Sham group was treated with CCl۴ (۱ mL/kg) dissolved in ۱ mL of olive oil to induce liver injury, identically. In control and sham groups, blood samples were collected at the beginning of week ۸. Finally, the experimental group after induction of liver injury, was injected with ۲×۱۰۶ AdSCs in the tail vein at the beginning of week ۸, while a blood sample was provided after ۳ and ۸ weeks following cell transplantation to determine liver function.Results: AdSC were spindle shape, positive for osteogenic and adipogenic inductions and expressed mesenchymal and lacked hematopoietic markers. Following cell transplantation, an improvement in albumin, total protein, and direct and indirect bilirubin were noticed denoting to repairing effect of AdSCs and treatment of liver injury.Conclusion: AdSCs improved liver function and acted as a promoting factor for liver regeneration. So they can be helpful for ameliorating hepatic injuries. These findings can be beneficial for cell therapy and can open a new era for researchers trying to improve mesenchymal stem cell therapeutic outcomes.
کلیدواژه ها:
نویسندگان
Davood Mehrabani
Li Ka Shing Center for Health Research and Innovation, University of Alberta, Edmonton, AB, Canada
Samin Arshi
Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran
Ladan Sadeghi
Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran
Zahra Khodabandeh
Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Shahrokh Zare
Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Mina Rabiee
University of Eastern Finland, Kuopio, Finland